Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Mol Microbiol. 2012 Nov 19;87(1):94–111. doi: 10.1111/mmi.12085

Table 5.

Regulation of the promoter of bcam0192 by CepR2, CepS, and OHLa.

Plasmid Fragment Genotype OHL (uM) β-Galacto- sidase Normalized Valueb
pGR136 −400 – +127 WT 0 32 ± 3 (1)
WT 1 367± 30 11.5
GR141 (cepR2-) 0 376 ± 31 11.8
GR141 (cepR2-) 1 368 ± 25 1.0
GR145 (cepS-) 0 3 ± 1 0.1
GR145 (cepS-) 1 4 ± 2 0.01
pGR137 −324 – +127 WT 0 78 ± 10 (1)
WT 1 357 ± 15 4.8
GR141 (cepR2-) 0 356 ± 23 4.6
GR141 (cepR2-) 1 374 ± 34 1.0
GR145 (cepS-) 0 7 ± 3 0.9
GR145 (cepS-) 1 5 ± 2 0.01
pGR138 −268 – +127 WT 0 217 ± 23 (1)
WT 1 263 ± 15 1.2
GR141 (cepR2-) 0 374 ± 18 1.7
GR141 (cepR2-) 1 382 ± 23 1.7
GR145 (cepS-) 0 4 ± 2 0.02
GR145 (cepS-) 1 7 ± 3 0.03
pGR139 −202 – +127 WT 0 370 ± 21 (1)
WT 1 375 ± 23 1.0
GR141 (cepR2-) 0 364 ± 26 1.0
GR141 (cepR2-) 1 384 ± 43 1.0
GR145 (cepS-) 0 12.5 ± 4 0.03
GR145 (cepS-) 1 18.7 ± 9 0.05
pGR140 −114 – +127 WT 0 5 ± 7 (1)
WT 1 4 ± 9 0.8
GR141 (cepR2-) 0 8 ± 6 1.6
GR141 (cepR2-) 1 5 ± 3 1.0
GR145 (cepS-) 0 3 ± 2 0.7
GR145 (cepS-) 1 3 ± 1 0.7
pGR243 −400 – -46 WT 0 75 ± 14 (1)
WT 1 332 ± 32 4.4
GR141 (cepR2-) 0 392 ± 32 5.2
GR141 (cepR2-) 1 421 ± 28 5.6
GR145 (cepS-) 0 2.4 ± 1.2 0.03
GR145 (cepS-) 1 5.6 ± 1.2 0.07
a

Derivatives of strain K56-I2 containing the indicated cepR2 or cepS mutations and the indicated plasmids were cultured at 37°C in LB supplemented with 300 μg ml−1 tetracycline to an optical density of approximately 0.4 in the presence or absence of 1 μM OHL, and assayed for β-galactosidase activity. Data were obtained from a single representative experiment using three independent isolates of each strain, each assayed once. Mean value and standard deviations are indicated.

b

β-galactosidase activity is normalized to that of the wild type strain carrying the indicated plasmid and cultured in the absence of OHL.